ARTICLE | Clinical News
NuThrax regulatory update
June 20, 2011 7:00 AM UTC
FDA granted Fast Track designation for Emergent's NuThrax to prevent anthrax infection. The vaccine, which is being developed under FDA's Animal Rule, is in Phase Ib testing for the indication. FDA's ...